Asset Details
Do you wish to reserve the book?
Development of nanoparticles derived from corn as mass producible bionanoparticles with anticancer activity
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Development of nanoparticles derived from corn as mass producible bionanoparticles with anticancer activity
Do you wish to request the book?
Development of nanoparticles derived from corn as mass producible bionanoparticles with anticancer activity
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Development of nanoparticles derived from corn as mass producible bionanoparticles with anticancer activity
2021
Overview
Recent studies showed that plant-derived nanoparticles (NPs) can be easily produced in high yields and have potential applications as therapeutic agents or delivery carriers for bioactive molecules. In this study, we selected corn as it is inexpensive to grow and mass-produced globally. Super sweet corn was homogenized in water to obtain corn juice, which was then centrifuged, filtered through a 0.45-μm-pore size syringe filter, and ultracentrifuged to obtain NPs derived from corn, or corn-derived NPs (cNPs). cNPs obtained were approximately 80 nm in diameter and negatively charged (− 17 mV). cNPs were taken up by various types of cells, including colon26 tumor cells and RAW264.7 macrophage-like cells, with selective reduction of the proliferation of colon26 cells. Moreover, cNPs induced tumor necrosis factor-α release from RAW264.7 cells. cNPs and RAW264.7 in combination significantly suppressed the proliferation of colon26/fluc cells. Daily intratumoral injections of cNPs significantly suppressed the growth of subcutaneous colon26 tumors in mice, with no significant body weight loss. These results indicate excellent anti-tumor activity of cNPs.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Animals
/ Antineoplastic Agents, Phytogenic - isolation & purification
/ Antineoplastic Agents, Phytogenic - metabolism
/ Antineoplastic Agents, Phytogenic - pharmacology
/ Cell Proliferation - drug effects
/ Colonic Neoplasms - drug therapy
/ Colonic Neoplasms - metabolism
/ Colonic Neoplasms - pathology
/ Corn
/ Female
/ Humanities and Social Sciences
/ Mice
/ Plant Extracts - isolation & purification
/ Plant Extracts - pharmacology
/ Plants
/ Science
/ Tumor Necrosis Factor-alpha - metabolism
/ Tumors
